Atossa Therapeutics Inc (NASDAQ:ATOS)
| 2.71 Delayed Data As of Feb 26 |  -0.20 / -6.87%Today’s Change | 0.76 Today|||52-Week Range 5.08 | +185.26% Year-to-Date |
Latest ATOS News | Press Releases
No recent news for Atossa Therapeutics Inc.
Today’s Trading
| Previous close | 2.91 |
| Today’s open | 3.33 |
| Day’s range | 2.51 - 2.91 |
| Volume | 341,146 |
| Average volume (3 months) | 15,342,393 |
| Market cap | $194.0M |
Data as of 3:59pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | +63.14% |
| Earnings growth (this year) | +45.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.98 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ISRIsoRay Inc | -0.08 | -5.48% |
| LFVNLifeVantage Corp | -0.16 | -1.80% |
| CDTXCidara Therapeutics ... | -0.16 | -6.58% |
| EVOKEvoke Pharma Inc | -0.13 | -4.18% |
Data as of 4:00pm ET, 02/26/2021
Financials
| Next reporting date | April 1, 2021 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$17.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
